{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:35:34Z","timestamp":1759541734443},"reference-count":32,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2020]]},"DOI":"10.2131\/jts.45.201","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T22:10:47Z","timestamp":1585692647000},"page":"201-218","source":"Crossref","is-referenced-by-count":2,"title":["Drug-induced lenticular opacity and accumulation of cholesterol-related substances in the lens cortex of dogs"],"prefix":"10.2131","volume":"45","author":[{"given":"Hiroshi","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Wakamatsu","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Sugihara","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyohei","family":"Kamio","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Morita","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Kurihara","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Izumi","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Pharmacokinetics Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohnosuke","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Pharmacokinetics Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Drug Safety Laboratories, Research Center, Taisho Pharmaceutical Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bassnett, S., Shi, Y. and Vrensen, G.F. (2011): Biological glass: structural determinants of eye lens transparency. Philos. Trans. R. Soc. Lond. B Biol. Sci., <b>366<\/b>, 1250-1264.","DOI":"10.1098\/rstb.2010.0302"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bron, A.J., Sparrow, J., Brown, N.A., Harding, J.J. and Blakytny, R. (1993): The lens in diabetes. Eye (Lond.), <b>7<\/b>, 260-275.","DOI":"10.1038\/eye.1993.60"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cenedella, R.J. and Bierkamper, G.G. (1979): Mechanism of cataract production by 3-beta(2-diethylaminoethoxy) androst-5-en-17-one hydrochloride, U18666A: an inhibitor of cholesterol biosynthesis. Exp. Eye Res., <b>28<\/b>, 673-688.","DOI":"10.1016\/0014-4835(79)90068-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Cenedella, R.J. (1996): Cholesterol and cataracts. Surv. Ophthalmol., <b>40<\/b>, 320-337.","DOI":"10.1016\/S0039-6257(96)82007-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"De Vries, A.C., Vermeer, M.A., Bredman, J.J., B\u00e4r, P.R. and Cohen, L.H. (1993): Cholesterol content of the rat lens is lowered by administration of simvastatin, but not by pravastatin. Exp. Eye Res., <b>56<\/b>, 393-399.","DOI":"10.1006\/exer.1993.1053"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gerson, R.J., MacDonald, J.S., Alberts, A.W., Chen, J., Yudkovitz, J.B., Greenspan, M.D., Rubin, L.F. and Bokelman, D.L. (1990): On the etiology of subcapsular lenticular opacities produced in dogs receiving HMG-CoA reductase inhibitors. Exp. Eye Res., <b>50<\/b>, 65-78.","DOI":"10.1016\/0014-4835(90)90012-J"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Harris, J.E. and Gruber, L. (1969): The reversal of triparanol-induced cataracts in the rat. Doc. Ophthalmol., <b>26<\/b>, 324-333.","DOI":"10.1007\/BF00943994"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Igarashi, F., Hikiba, J., Ogihara, M.H., Nakaoka, T., Suzuki, M. and Kataoka, H. (2011): A highly specific and sensitive quantification analysis of the sterols in silkworm larvae by high performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. Anal. Biochem., <b>419<\/b>, 123-132.","DOI":"10.1016\/j.ab.2011.08.046"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Jobling, A.I. and Augusteyn, R.C. (2002): What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin. Exp. Optom., <b>85<\/b>, 61-75.","DOI":"10.1111\/j.1444-0938.2002.tb03011.x"},{"key":"10","unstructured":"Kirby, T.J. (1967): Cataracts produced by triparanol. (MER-29). Trans. Am. Ophthalmol. Soc., <b>65<\/b>, 494-543."},{"key":"11","unstructured":"Kuwabara, T., Kinoshita, J.H. and Cogan, D.G. (1969): Electron microscopic study of galactose-induced cataract. Invest. Ophthalmol., <b>8<\/b>, 133-149."},{"key":"12","doi-asserted-by":"crossref","unstructured":"MacDonald, J.S., Gerson, R.J., Kornbrust, D.J., Kloss, M.W., Prahalada, S., Berry, P.H., Alberts, A.W. and Bokelman, D.L. (1988): Preclinical evaluation of lovastatin. Am. J. Cardiol., <b>62<\/b>, 16J-27J.","DOI":"10.1016\/0002-9149(88)90003-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Moreau, K.L. and King, J.A. (2012): Protein misfolding and aggregation in cataract disease and prospects for prevention. Trends Mol. Med., <b>18<\/b>, 273-282.","DOI":"10.1016\/j.molmed.2012.03.005"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Nakano-Ito, K., Fujikawa, Y., Hihara, T., Shinjo, H., Kotani, S., Suganuma, A., Aoki, T. and Tsukidate, K. (2014): E2012-induced cataract and its predictive biomarkers. Toxicol. Sci., <b>137<\/b>, 249-258.","DOI":"10.1093\/toxsci\/kft224"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Pyrah, I.T., Kalinowski, A., Jackson, D., Davies, W., Davis, S., Aldridge, A. and Greaves, P. (2001): Toxicologic lesions associated with two related inhibitors of oxidosqualene cyclase in the dog and mouse. Toxicol. Pathol., <b>29<\/b>, 174-179.","DOI":"10.1080\/019262301317052440"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Rao, P.V. (2008): The pulling, pushing and fusing of lens fibers: a role for Rho GTPases. Cell Adhes. Migr., <b>2<\/b>, 170-173.","DOI":"10.4161\/cam.2.3.6495"},{"key":"17","unstructured":"Rodr\u00edguez-Sargent, C., Cangiano, J.L., Berr\u00edos Cab\u00e1n, G., Marrero, E. and Mart\u00ednez-Maldonado, M. (1987): Cataracts and hypertension in salt-sensitive rats. A possible ion transport defect. Hypertension, <b>9<\/b>, 304-308."},{"key":"18","unstructured":"Ross, W.M., Creighton, M.O., Trevithick, J.R., Stewart-DeHaan, P.J. and Sanwal, M. (1983): Modelling cortical cataractogenesis: VI. Induction by glucose <i>in vitro<\/i> or in diabetic rats: prevention and reversal by glutathione. Exp. Eye Res., <b>37<\/b>, 559-573."},{"key":"19","unstructured":"Saito, T., Ando, R., Ohira, T., Hoshiya, T. and Tamura, K. (2015): Ocular lesions induced in infant rats by busulfan. Histol. Histopathol., <b>30<\/b>, 321-330."},{"key":"20","unstructured":"Sato, S., Takahashi, Y., Wyman, M. and Kador, P.F. (1991): Progression of sugar cataract in the dog. Invest. Ophthalmol. Vis. Sci., <b>32<\/b>, 1925-1931."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Schiavo, D.M., Field, W.E. and Vymetal, F.J. (1975): Cataracts in beagle dogs given diazoxide. Diabetes, <b>24<\/b>, 1041-1049.","DOI":"10.2337\/diab.24.12.1041"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Song, S., Landsbury, A., Dahm, R., Liu, Y., Zhang, Q. and Quinlan, R.A. (2009): Functions of the intermediate filament cytoskeleton in the eye lens. J. Clin. Invest., <b>119<\/b>, 1837-1848.","DOI":"10.1172\/JCI38277"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Thompson, J. and Lakhani, N. (2015): Cataracts. Prim. Care, <b>42<\/b>, 409-423.","DOI":"10.1016\/j.pop.2015.05.012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Vemuri, R. and Philipson, K.D. (1989): Influence of sterols and phospholipids on sarcolemmal and sarcoplasmic reticular cation transporters. J. Biol. Chem., <b>264<\/b>, 8680-8685.","DOI":"10.1016\/S0021-9258(18)81846-4"},{"key":"25","doi-asserted-by":"crossref","unstructured":"von Sallmann, L., Grimes, P. and Collins, E. (1963): TRIPARANOL INDUCED CATARACT IN RATS. Trans. Am. Ophthalmol. Soc., <b>61<\/b>, 49-60.","DOI":"10.1001\/archopht.1963.00960050524016"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Walsh, K.M., Albassam, M.A. and Clarke, D.E. (1996): Subchronic toxicity of atorvastatin, a hydroxymethylglutaryl-coenzyme A reductase inhibitor, in beagle dogs. Toxicol. Pathol., <b>24<\/b>, 468-476.","DOI":"10.1177\/019262339602400409"},{"key":"27","unstructured":"Wang, Z., Hess, J.L. and Bunce, G.E. (1992): Deferoxamine effect on selenite-induced cataract formation in rats. Invest. Ophthalmol. Vis. Sci., <b>33<\/b>, 2511-2519."},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wojnar, W., Kaczmarczyk-Sedlak, I. and Zych, M. (2017): Diosmin ameliorates the effects of oxidative stress in lenses of streptozotocin-induced type 1 diabetic rats. Pharmacol. Rep., <b>69<\/b>, 995-1000.","DOI":"10.1016\/j.pharep.2017.04.005"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Xu, L., Liu, W., Sheflin, L.G., Fliesler, S.J. and Porter, N.A. (2011): Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J. Lipid Res., <b>52<\/b>, 1810-1820.","DOI":"10.1194\/jlr.M018366"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Xu, L., Korade, Z. and Porter, N.A. (2010): Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies. J. Am. Chem. Soc., <b>132<\/b>, 2222-2232.","DOI":"10.1021\/ja9080265"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Zelenka, P.S. (1984): Lens lipids. Curr. Eye Res., <b>3<\/b>, 1337-1359.","DOI":"10.3109\/02713688409007421"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Zhang, X., Taylor, A., Liu, Y. and Shang, F. (2017): Glutathiolation triggers proteins for degradation by the ubiquitin-proteasome pathway. Curr. Mol. Med., <b>17<\/b>, 258-269.","DOI":"10.2174\/1566524017666171101165021"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/45\/4\/45_201\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T21:25:05Z","timestamp":1615065905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/45\/4\/45_201\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.45.201","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}